Published in Science on July 18, 2013
Retracted Stimulus-triggered fate conversion of somatic cells into pluripotency. Nature (2014) 6.57
Systematic identification of culture conditions for induction and maintenance of naive human pluripotency. Cell Stem Cell (2014) 2.68
In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer's disease model. Cell Stem Cell (2013) 2.26
Chromatin dynamics during cellular reprogramming. Nature (2013) 1.79
A continuous molecular roadmap to iPSC reprogramming through progression analysis of single-cell mass cytometry. Cell Stem Cell (2015) 1.67
Hallmarks of pluripotency. Nature (2015) 1.60
Use of induced pluripotent stem cells to recapitulate pulmonary alveolar proteinosis pathogenesis. Am J Respir Crit Care Med (2014) 1.53
A comparison of non-integrating reprogramming methods. Nat Biotechnol (2014) 1.49
Small molecule-driven direct conversion of human pluripotent stem cells into functional osteoblasts. Sci Adv (2016) 1.42
Rethinking differentiation: stem cells, regeneration, and plasticity. Cell (2014) 1.41
iPS cell-derived cardiogenicity is hindered by sustained integration of reprogramming transgenes. Circ Cardiovasc Genet (2014) 1.40
Generation of neural progenitor cells by chemical cocktails and hypoxia. Cell Res (2014) 1.30
Molecular control of induced pluripotency. Cell Stem Cell (2014) 1.22
Kinome-wide functional analysis highlights the role of cytoskeletal remodeling in somatic cell reprogramming. Cell Stem Cell (2014) 1.19
Platform for induction and maintenance of transgene-free hiPSCs resembling ground state pluripotent stem cells. Stem Cell Reports (2014) 1.18
Failure to replicate the STAP cell phenomenon. Nature (2015) 1.17
A decade of transcription factor-mediated reprogramming to pluripotency. Nat Rev Mol Cell Biol (2016) 1.16
Retinal repair with induced pluripotent stem cells. Transl Res (2013) 1.09
Reactive oxygen species in normal and tumor stem cells. Adv Cancer Res (2014) 1.06
Pluripotent stem cell energy metabolism: an update. EMBO J (2014) 1.05
Reprogramming of cell fate: epigenetic memory and the erasure of memories past. EMBO J (2015) 1.05
Small molecules facilitate rapid and synchronous iPSC generation. Nat Methods (2014) 1.04
A systematic evaluation of integration free reprogramming methods for deriving clinically relevant patient specific induced pluripotent stem (iPS) cells. PLoS One (2013) 1.03
Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice. Stem Cell Res Ther (2015) 1.01
Do all roads lead to Oct4? the emerging concepts of induced pluripotency. Trends Cell Biol (2013) 0.98
Small Molecules Efficiently Reprogram Human Astroglial Cells into Functional Neurons. Cell Stem Cell (2015) 0.98
Notch inhibition allows oncogene-independent generation of iPS cells. Nat Chem Biol (2014) 0.95
Transient acid treatment cannot induce neonatal somatic cells to become pluripotent stem cells. F1000Res (2014) 0.94
Cellular reprogramming of human peripheral blood cells. Genomics Proteomics Bioinformatics (2013) 0.94
Small molecule screening in human induced pluripotent stem cell-derived terminal cell types. J Biol Chem (2013) 0.93
Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies. Stem Cells Transl Med (2015) 0.92
Early reprogramming regulators identified by prospective isolation and mass cytometry. Nature (2015) 0.92
All roads lead to induced pluripotent stem cells: the technologies of iPSC generation. Stem Cells Dev (2014) 0.91
Application of biomaterials to advance induced pluripotent stem cell research and therapy. EMBO J (2015) 0.90
Novel codon-optimized mini-intronic plasmid for efficient, inexpensive, and xeno-free induction of pluripotency. Sci Rep (2015) 0.90
Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails. Cell Res (2015) 0.89
Differentiation of human ESCs to retinal ganglion cells using a CRISPR engineered reporter cell line. Sci Rep (2015) 0.89
Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of "factor-free" induced pluripotent stem cells. Mol Ther (2014) 0.89
Concise review: Stem cell therapies for amyotrophic lateral sclerosis: recent advances and prospects for the future. Stem Cells (2014) 0.89
Back to the future: how human induced pluripotent stem cells will transform regenerative medicine. Hum Mol Genet (2013) 0.89
Generation of pluripotent stem cells without the use of genetic material. Lab Invest (2014) 0.88
Adult Stem Cells and Diseases of Aging. J Clin Med (2014) 0.88
Induced pluripotent stem cell (iPSCs) and their application in immunotherapy. Cell Mol Immunol (2013) 0.88
Induced pluripotent stem cells for regenerative medicine. Annu Rev Biomed Eng (2014) 0.88
Advances in understanding the cell types and approaches used for generating induced pluripotent stem cells. J Hematol Oncol (2014) 0.88
Clinical therapy using iPSCs: hopes and challenges. Genomics Proteomics Bioinformatics (2013) 0.87
Transitions between epithelial and mesenchymal states during cell fate conversions. Protein Cell (2014) 0.87
Reprogramming with Small Molecules instead of Exogenous Transcription Factors. Stem Cells Int (2015) 0.87
The implementation of novel collaborative structures for the identification and resolution of barriers to pluripotent stem cell translation. Stem Cells Dev (2013) 0.86
Reprogramming antitumor immunity. Trends Immunol (2014) 0.86
Integration-free methods for generating induced pluripotent stem cells. Genomics Proteomics Bioinformatics (2013) 0.86
Collaborative rewiring of the pluripotency network by chromatin and signalling modulating pathways. Nat Commun (2015) 0.86
The use of small molecules in somatic-cell reprogramming. Trends Cell Biol (2013) 0.85
Skeletal muscle tissue engineering: methods to form skeletal myotubes and their applications. Tissue Eng Part B Rev (2014) 0.85
Induced Pluripotent Stem Cells in Huntington's Disease Research: Progress and Opportunity. J Huntingtons Dis (2016) 0.85
Chemical approaches to cell reprogramming. Curr Opin Genet Dev (2014) 0.85
Efficient germ-line transmission obtained with transgene-free induced pluripotent stem cells. Proc Natl Acad Sci U S A (2014) 0.85
Understanding the roadmaps to induced pluripotency. Cell Death Dis (2014) 0.85
Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine. J Am Coll Cardiol (2016) 0.85
Methods of induced pluripotent stem cells for clinical application. World J Stem Cells (2015) 0.85
OSKM Induce Extraembryonic Endoderm Stem Cells in Parallel to Induced Pluripotent Stem Cells. Stem Cell Reports (2016) 0.84
Immunogenicity and tumorigenicity of pluripotent stem cells and their derivatives: genetic and epigenetic perspectives. Curr Stem Cell Res Ther (2014) 0.84
On human pluripotent stem cell control: The rise of 3D bioengineering and mechanobiology. Biomaterials (2015) 0.84
Targeting molecular networks for drug research. Front Genet (2014) 0.84
Enhancing RPE Cell-Based Therapy Outcomes for AMD: The Role of Bruch's Membrane. Transl Vis Sci Technol (2014) 0.83
Induced pluripotent stem cell-derived vascular smooth muscle cells: methods and application. Biochem J (2015) 0.83
Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity. Stem Cell Res Ther (2015) 0.83
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells. Nat Neurosci (2016) 0.83
Bromodeoxyuridine promotes full-chemical induction of mouse pluripotent stem cells. Cell Res (2015) 0.83
Mechanisms for enhancing cellular reprogramming. Curr Opin Genet Dev (2014) 0.82
NanoScript: a nanoparticle-based artificial transcription factor for effective gene regulation. ACS Nano (2014) 0.82
Sphere formation permits Oct4 reprogramming of ciliary body epithelial cells into induced pluripotent stem cells. Stem Cells Dev (2014) 0.82
Cell signalling pathways underlying induced pluripotent stem cell reprogramming. World J Stem Cells (2014) 0.82
Mesenchymal and induced pluripotent stem cells: general insights and clinical perspectives. Stem Cells Cloning (2015) 0.82
Inhibition of transforming growth factor β (TGF-β) signaling can substitute for Oct4 protein in reprogramming and maintain pluripotency. J Biol Chem (2014) 0.82
Pluripotent stem cells induced from mouse neural stem cells and small intestinal epithelial cells by small molecule compounds. Cell Res (2015) 0.82
Highly efficient direct conversion of human fibroblasts to neuronal cells by chemical compounds. J Clin Biochem Nutr (2015) 0.82
Pluripotent stem cell derived cardiomyocytes for cardiac repair. Curr Treat Options Cardiovasc Med (2014) 0.82
Sp7/Osterix Is Restricted to Bone-Forming Vertebrates where It Acts as a Dlx Co-factor in Osteoblast Specification. Dev Cell (2016) 0.82
Metabolic control of cancer cell stemness: Lessons from iPS cells. Cell Cycle (2015) 0.81
Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications. Stem Cell Rev (2017) 0.81
Recent technological updates and clinical applications of induced pluripotent stem cells. Korean J Intern Med (2014) 0.81
Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells. PLoS One (2015) 0.81
Induced pluripotent stem cells: challenges and opportunities for cancer immunotherapy. Front Immunol (2014) 0.81
Transposable elements at the center of the crossroads between embryogenesis, embryonic stem cells, reprogramming, and long non-coding RNAs. Sci Bull (Beijing) (2015) 0.81
StemCellNet: an interactive platform for network-oriented investigations in stem cell biology. Nucleic Acids Res (2014) 0.81
CD24 tracks divergent pluripotent states in mouse and human cells. Nat Commun (2015) 0.81
Toward pluripotency by reprogramming: mechanisms and application. Protein Cell (2013) 0.81
Reprogramming fibroblasts to pluripotency using arginine-terminated polyamidoamine nanoparticles based non-viral gene delivery system. Int J Nanomedicine (2014) 0.81
Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency. Epigenomics (2016) 0.81
Increased genomic integrity of an improved protein-based mouse induced pluripotent stem cell method compared with current viral-induced strategies. Stem Cells Transl Med (2014) 0.80
Development of stem cell-based therapy for Parkinson's disease. Transl Neurodegener (2015) 0.80
Identification of hematopoietic-specific regulatory elements from the CD45 gene and use for lentiviral tracking of transplanted cells. Exp Hematol (2014) 0.80
Prospects for clinical use of reprogrammed cells for autologous treatment of macular degeneration. Fibrogenesis Tissue Repair (2015) 0.80
On the road to bioartificial organs. Pflugers Arch (2014) 0.80
Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy. Mol Neurodegener (2016) 0.80
Identification of small activating RNAs that enhance endogenous OCT4 expression in human mesenchymal stem cells. Stem Cells Dev (2014) 0.80
Direct Conversion of Cord Blood CD34+ Cells Into Neural Stem Cells by OCT4. Stem Cells Transl Med (2015) 0.80
hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine. J Cell Mol Med (2016) 0.80
Neurodegenerative diseases in a dish: the promise of iPSC technology in disease modeling and therapeutic discovery. Neurol Sci (2014) 0.80
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol (2006) 30.90
Genome-wide association study of 107 phenotypes in Arabidopsis thaliana inbred lines. Nature (2010) 10.66
Abscisic acid inhibits type 2C protein phosphatases via the PYR/PYL family of START proteins. Science (2009) 10.21
Differential antigen processing by dendritic cell subsets in vivo. Science (2007) 8.42
A model of (often mixed) stereotype content: competence and warmth respectively follow from perceived status and competition. J Pers Soc Psychol (2002) 7.36
A draft sequence for the genome of the domesticated silkworm (Bombyx mori). Science (2004) 6.62
Origin of the lamina propria dendritic cell network. Immunity (2009) 5.95
Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol (2010) 5.92
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. J Clin Oncol (2014) 5.80
Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol Cell (2007) 5.49
Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat Biotechnol (2006) 5.14
Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell (2008) 5.04
The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat Immunol (2008) 4.86
The origin and development of nonlymphoid tissue CD103+ DCs. J Exp Med (2009) 4.79
The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med (2002) 4.78
Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell (2008) 4.63
A visual motion detection circuit suggested by Drosophila connectomics. Nature (2013) 3.94
The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J Exp Med (2004) 3.59
Simultaneous phase and size control of upconversion nanocrystals through lanthanide doping. Nature (2010) 3.53
Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res (2009) 3.44
Histone H3 and H4 ubiquitylation by the CUL4-DDB-ROC1 ubiquitin ligase facilitates cellular response to DNA damage. Mol Cell (2006) 3.39
Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology (2007) 3.29
Retrograde light-guided laryngoscopy for tracheal intubation: clinical practice and comparison with conventional direct laryngoscopy. Anesthesiology (2013) 3.22
Genome sequencing reveals insights into physiology and longevity of the naked mole rat. Nature (2011) 3.19
Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol (2012) 3.18
Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell (2008) 3.15
Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J Exp Med (2009) 3.13
Functional specialization of beta-arrestin interactions revealed by proteomic analysis. Proc Natl Acad Sci U S A (2007) 3.08
Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol (2012) 3.04
Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res (2004) 3.03
The use and interpretation of competing risks regression models. Clin Cancer Res (2012) 3.01
The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles. Nat Nanotechnol (2011) 2.98
NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activation. J Clin Invest (2015) 2.93
Lifestyle change and mobility in obese adults with type 2 diabetes. N Engl J Med (2012) 2.90
Gold nanocages covered by smart polymers for controlled release with near-infrared light. Nat Mater (2009) 2.85
Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res (2009) 2.74
A large number of novel coding small open reading frames in the intergenic regions of the Arabidopsis thaliana genome are transcribed and/or under purifying selection. Genome Res (2007) 2.72
Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta. J Immunol (2007) 2.69
Induction of pluripotency in mouse somatic cells with lineage specifiers. Cell (2013) 2.69
Complete resequencing of 40 genomes reveals domestication events and genes in silkworm (Bombyx). Science (2009) 2.68
Groundwater arsenic contamination throughout China. Science (2013) 2.64
Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat Med (2004) 2.64
Notch2 receptor signaling controls functional differentiation of dendritic cells in the spleen and intestine. Immunity (2011) 2.61
The HIV epidemic in Yunnan Province, China, 1989-2007. J Acquir Immune Defic Syndr (2010) 2.61
Prevalence of vision impairment in older adults in rural China: the China Nine-Province Survey. Ophthalmology (2010) 2.61
Integrative genomic and functional analyses reveal neuronal subtype differentiation bias in human embryonic stem cell lines. Proc Natl Acad Sci U S A (2007) 2.60
Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain. Proc Natl Acad Sci U S A (2002) 2.60
Reactive oxygen species as a signal in glucose-stimulated insulin secretion. Diabetes (2007) 2.59
Humanized mice for modeling human infectious disease: challenges, progress, and outlook. Cell Host Microbe (2009) 2.58
Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nat Med (2005) 2.55
Expectation-maximization-driven geodesic active contour with overlap resolution (EMaGACOR): application to lymphocyte segmentation on breast cancer histopathology. IEEE Trans Biomed Eng (2010) 2.52
Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility. Nature (2013) 2.52
Interaction with vesicle luminal protachykinin regulates surface expression of delta-opioid receptors and opioid analgesia. Cell (2005) 2.52
Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage. J Exp Med (2012) 2.51
Facilitation of μ-opioid receptor activity by preventing δ-opioid receptor-mediated codegradation. Neuron (2011) 2.42
Controlling the synthesis and assembly of silver nanostructures for plasmonic applications. Chem Rev (2011) 2.40
Autophagy negatively regulates Wnt signalling by promoting Dishevelled degradation. Nat Cell Biol (2010) 2.37
Qualitative and quantitative measures of various compounded formulations of 17-alpha hydroxyprogesterone caproate. Am J Obstet Gynecol (2013) 2.36
Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann N Y Acad Sci (2003) 2.36
Prion detection by an amyloid seeding assay. Proc Natl Acad Sci U S A (2007) 2.34
In vivo molecular photoacoustic tomography of melanomas targeted by bioconjugated gold nanocages. ACS Nano (2010) 2.29
In vitro derivation of functional insulin-producing cells from human embryonic stem cells. Cell Res (2007) 2.28
Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet (2012) 2.26
Targeted synthesis of a porous aromatic framework with high stability and exceptionally high surface area. Angew Chem Int Ed Engl (2009) 2.22
Microarray-based gene expression profiles in multiple tissues of the domesticated silkworm, Bombyx mori. Genome Biol (2007) 2.21
Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J Immunol (2009) 2.19
Energy policy: A low-carbon road map for China. Nature (2013) 2.18
Disruption of tumor neovasculature by microbubble enhanced ultrasound: a potential new physical therapy of anti-angiogenesis. Ultrasound Med Biol (2011) 2.18
Short-term BMP-4 treatment initiates mesoderm induction in human embryonic stem cells. Blood (2007) 2.18
Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice. Hepatology (2014) 2.17
Patellar resurfacing versus nonresurfacing in total knee arthroplasty: a meta-analysis of randomised controlled trials. Int Orthop (2013) 2.13
Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy. Mol Cell Proteomics (2008) 2.08
Corneal immunity is mediated by heterogeneous population of antigen-presenting cells. J Leukoc Biol (2003) 2.08
The corneal stroma is endowed with a significant number of resident dendritic cells. Invest Ophthalmol Vis Sci (2003) 2.05
An infectious disease of ducks caused by a newly emerged Tembusu virus strain in mainland China. Virology (2011) 2.05
Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules. Cell Res (2010) 2.04
Clinical short-term results of radiofrequency ablation in liver cancers. World J Gastroenterol (2002) 2.04
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial. Lancet Oncol (2011) 2.03
The draft genome of the parasitic nematode Trichinella spiralis. Nat Genet (2011) 2.03